Il Trattamento Del Carcinoma Prostatico Avanzato Con Epirubicina

Ahamed S.R. , Brooman P.J.C. , Shalet S.M. : Treatment of advanced prostatic cancer with LH-RH analogue ICI-118630: clinical response and hormonal mechanism. Lancet, II; 415–419 (1983).

Huggins C. , Hodges C.V. : Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res., 1; 293–297 (1941).

Huggins C. , Stevens R.E. Jr. , Hodges C.V. : Studies on prostatic cancer. II. The effect of castration on advanced carcinoma of the prostate gland. Arch. Surg., 43; 209–223 (1941).

Huggins C. , Scott W.W. , Hodges C.V. : Studies on prostatic cancer. III. The effects of fever, of desoxycorticosterone and of estrogen on clinical patients with metastatic carcinoma of the prostate. J. Urol., 46; 997–1006 (1941).

Jones W.G. , Fossa S.D. , Bono A.V. : European Organization for Research and Treatment of Cancer (EORTC). Phase II. Study of low dose weekly epirubicin in metastatic prostate cancer. Cancer Treat. Rep., 71; 1317–1318 (1987).

Labrie F. , Dupont A. , Belanger A. : Treatment of prostate cancer with gonadotropin-releasing hormone agonist. Endocrine Rev., 8; 67–74 (1986).

Piras P. , Manca G.P. , Bordoni P.P. , D'Alpaos M. : Farmorubicina nel cancro prostatico avanzato: nostra esperienza. Atti del Convegno Intern. Cancro Prostata, p. 295–297. Monduzzi Editore, Bologna 1988.